Vaxcyte, Inc. - FORM S-1 - EX-23.1 - May 22, 2020

Attached files

file filename
S-1 - S-1 - Vaxcyte, Inc.d802328ds1.htm
EX-10.23 - EX-10.23 - Vaxcyte, Inc.d802328dex1023.htm
EX-10.22 - EX-10.22 - Vaxcyte, Inc.d802328dex1022.htm
EX-10.21 - EX-10.21 - Vaxcyte, Inc.d802328dex1021.htm
EX-10.20 - EX-10.20 - Vaxcyte, Inc.d802328dex1020.htm
EX-10.19 - EX-10.19 - Vaxcyte, Inc.d802328dex1019.htm
EX-10.18 - EX-10.18 - Vaxcyte, Inc.d802328dex1018.htm
EX-10.17 - EX-10.17 - Vaxcyte, Inc.d802328dex1017.htm
EX-10.16 - EX-10.16 - Vaxcyte, Inc.d802328dex1016.htm
EX-10.15 - EX-10.15 - Vaxcyte, Inc.d802328dex1015.htm
EX-10.14 - EX-10.14 - Vaxcyte, Inc.d802328dex1014.htm
EX-10.13 - EX-10.13 - Vaxcyte, Inc.d802328dex1013.htm
EX-10.12 - EX-10.12 - Vaxcyte, Inc.d802328dex1012.htm
EX-10.11 - EX-10.11 - Vaxcyte, Inc.d802328dex1011.htm
EX-10.10 - EX-10.10 - Vaxcyte, Inc.d802328dex1010.htm
EX-10.9 - EX-10.9 - Vaxcyte, Inc.d802328dex109.htm
EX-10.8 - EX-10.8 - Vaxcyte, Inc.d802328dex108.htm
EX-10.7 - EX-10.7 - Vaxcyte, Inc.d802328dex107.htm
EX-10.6 - EX-10.6 - Vaxcyte, Inc.d802328dex106.htm
EX-10.5 - EX-10.5 - Vaxcyte, Inc.d802328dex105.htm
EX-10.2 - EX-10.2 - Vaxcyte, Inc.d802328dex102.htm
EX-10.1 - EX-10.1 - Vaxcyte, Inc.d802328dex101.htm
EX-3.2 - EX-3.2 - Vaxcyte, Inc.d802328dex32.htm
EX-3.1 - EX-3.1 - Vaxcyte, Inc.d802328dex31.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated March 13, 2020 relating to the financial statements of Vaxcyte, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

San Francisco, California

May 22, 2020

Vaxcyte, Inc. Reports